Oncogene - Table of Contents alert Volume 30 Issue 40

TABLE OF CONTENTS Volume 30, Issue 40 (October 2011) In this issue Review Original Articles Also new AOP Advertisment NEW! Agilent CytoGenomics 1.5 Software for LOH and UPD detection! An automated analysis path has been created for CGH+SNP microarray data analysis, providing greater efficiency and throughput in the cytogenetic research lab. CytoGenomics 1.5 Software helps put biological data into context, with internal database comparisons and links to external databases. Visit www.agilent.com/genomics/cyto_software Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take a look at this recent article published in Gene Therapy: CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors FREE A Gaussin , U Modlich , C Bauche , N J Niederlander , A Schambach et al doi:10.1038/gt.2011.70   Review Top Molecular imaging of tumor metabolism and apoptosis U Haberkorn, A Markert, W Mier, V Askoxylakis and A Altmann Oncogene 2011 30: 4141-4151; advance online publication, May 16, 2011; 10.1038/onc.2011.169 Abstract | Full Text Original Articles Top MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma Y Zhai, A Iura, S Yeasmin, A B Wiese, R Wu, Y Feng, E R Fearon and K R Cho Oncogene 2011 30: 4152-4162; advance online publication, April 18, 2011; 10.1038/onc.2011.123 Abstract | Full Text Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition B N Rexer, A-J L Ham, C Rinehart, S Hill, N de Matos Granja-Ingram, A M González-Angulo, G B Mills, B Dave, J C Chang, D C Liebler and C L Arteaga Oncogene 2011 30: 4163-4174; advance online publication, April 18, 2011; 10.1038/onc.2011.130 Abstract | Full Text Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response Y-H Lee, A D Judge, D Seo, M Kitade, L E Gómez-Quiroz, T Ishikawa, J B Andersen, B-K Kim, J U Marquardt, C Raggi, I Avital, E A Conner, I MacLachlan, V M Factor and S S Thorgeirsson Oncogene 2011 30: 4175-4184; advance online publication, April 18, 2011; 10.1038/onc.2011.126 Abstract | Full Text LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms C E King, L Wang, R Winograd, B B Madison, P S Mongroo, C N Johnstone and A K Rustgi Oncogene 2011 30: 4185-4193; advance online publication, May 30, 2011; 10.1038/onc.2011.131 Abstract | Full Text Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation I Nishikata, S Nakahata, Y Saito, K Kaneda, E Ichihara, N Yamakawa and K Morishita Oncogene 2011 30: 4194-4207; advance online publication, April 25, 2011; 10.1038/onc.2011.132 Abstract | Full Text Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis A Morinaka, Y Funato, K Uesugi and H Miki Oncogene 2011 30: 4208-4218; advance online publication, April 25, 2011; 10.1038/onc.2011.139 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.